Corporate Responsibility With Teeth: GSK’s Developing Countries Unit
Executive Summary
Initiative to build health care infrastructure and create a sales channel for GSK medicines is starting to yield tangible results.
You may also be interested in...
Janssen Forms Global Public Health Group To Deliver Its Medicines To Developing World
With the formation of the GPH group, Janssen joins GSK and Sanofi in putting corporate focus on developing and delivering affordable medicines for developing countries. But where GSK seeks to improve outcomes and turn a profit, for now Janssen’s first priority is human health.
Janssen Forms Global Public Health Group To Deliver Its Medicines To Developing World
With the formation of the GPH group, Janssen joins GSK and Sanofi in putting corporate focus on developing and delivering affordable medicines for developing countries. But where GSK seeks to improve outcomes and turn a profit, for now Janssen’s first priority is human health.
Vaccine Funding And Access Key To Pharma Success In Developing World
Vaccine consultant Jacqueline Keith in an interview described promising advances but also challenges to the funding, development, and delivery of vaccines to the neediest populations. The role of public/private partnerships at each stage of the vaccine value chain is critical to assuring win-win outcomes.